Neuronetics is trading 10.08% down at $2.14, with no clear company-specific announcement identified to explain the decline during early trading.
- Compared with its August 7, 2026 close of $2.38.
- Investors may be positioning cautiously before Neuronetics reports second-quarter 2026 results before market open on August 11, 2026, but this is not confirmed as the cause.
- Broader markets are mixed and do not explain the move.